Oscotec Inc. (KOSDAQ:039200)
27,750
-300 (-1.07%)
Jun 16, 2025, 1:49 PM KST
Oscotec Revenue
Oscotec had revenue of 1.94B KRW in the quarter ending March 31, 2025, with 82.34% growth. This brings the company's revenue in the last twelve months to 34.88B, up 617.11% year-over-year. In the year 2024, Oscotec had annual revenue of 34.01B with 586.89% growth.
Revenue (ttm)
34.88B
Revenue Growth
+617.11%
P/S Ratio
30.76
Revenue / Employee
683.96M
Employees
51
Market Cap
1,072.86B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 34.01B | 29.06B | 586.89% |
Dec 31, 2023 | 4.95B | -111.45M | -2.20% |
Dec 31, 2022 | 5.06B | 1.16B | 29.71% |
Dec 31, 2021 | 3.90B | -39.57B | -91.02% |
Dec 31, 2020 | 43.47B | 39.10B | 895.09% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
Peptron | 4.30B |